New hope for Hard-to-Treat myeloma: first human trial launches

NCT ID NCT05862012

Recruiting now Disease control Sponsor: Ichnos Sciences SA Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called ISB 2001 in people with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check the drug's safety and how well it fights the cancer. About 200 participants will receive the drug in increasing doses to find the best and safest amount.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSED/REFRACTORY MULTIPLE MYELOMA

Contacts and locations

Locations

ASST Spedali Civili di Brescia
ACTIVE_NOT_RECRUITING

Brescia, Lombardy, 25123, Italy
Apollo Cancer Centers
ACTIVE_NOT_RECRUITING

Hyderabad, Telangana, 500033, India
Apollo Hospital International Limited
ACTIVE_NOT_RECRUITING

Gandhinagar, Gujarat, 382428, India
Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02215, United States
CHRU Lille
RECRUITING

Lille, Hauts-de-France, 59800, France
CHU Poiters - Hospital la Miletrie
RECRUITING

Poitiers, New Aquitaine, 86021, France
CHU de Nantes - Hotel Dieu
RECRUITING

Nantes, Pays de la Loire Region, 44093, France
Centro Integral Oncologici Clara Campal
ACTIVE_NOT_RECRUITING

Madrid, Madrid, 28050, Spain
Clinica Universidad de Nevarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Concord Hospital
RECRUITING

Concord, New South Wales, 2139, Australia
Deenanath Mangeshkar Hospital and Research Centre
ACTIVE_NOT_RECRUITING

Pune, Maharashta, 411004, India
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
RECRUITING

Milan, Lombardy, 20122, Italy
Froedtert Hospital & the Medical College of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States
Groupe Hospitalier Pitie-Salpetriere
RECRUITING

Paris, Île-de-France Region, 75013, France
HCG Hospital
ACTIVE_NOT_RECRUITING

Bangalore, India
Health Care Global Enterprises Ltd.
ACTIVE_NOT_RECRUITING

Bangalore, Karnataka, 560027, India
Hospital Clinic de Barcelona
RECRUITING

Barcelona, Catalonia, 08036, Spain
Institut Catala de Oncologia (ICO)
RECRUITING

Badalona, Catalonia, 08916, Spain
Instituto de Investigacion Biomedica de Salamanca (IBSAL)
RECRUITING

Salamanca, Castile de Leon, 37007, Spain
Linear Clinical Research
RECRUITING

Nedlands, Western Australia, 6009, Australia
Montefiore Medical Center
RECRUITING

The Bronx, New York, 10467, United States
Oslo University Hospital
RECRUITING

Oslo, Oslo, 0372, Norway
Peter MacCallum Cancer Center
RECRUITING

Melbourne, Victoria, 3000, Australia
Pindara Private Hospital
RECRUITING

Benowa, Queensland, 4217, Australia
St. Vincent's Hospital Melbourne
RECRUITING

Fitzroy, Victoria, 3065, Australia
Standford Cancer Institute
RECRUITING

Palo Alto, California, 94304, United States
Sylvester Cancer Center
ACTIVE_NOT_RECRUITING

Miami, Florida, 33136, United States
Tennessee Oncology
ACTIVE_NOT_RECRUITING

Nashville, Tennessee, 37203, United States
University of Chicago Medical Center
RECRUITING

Chicago, Illinois, 60637, United States
University of North Carolina
RECRUITING

Chapel Hill, North Carolina, 27599, United States
Virginia Commonwealth University (VCU)
ACTIVE_NOT_RECRUITING

Richmond, Virginia, 23298, United States
Winship Cancer Institute
RECRUITING

Atlanta, Georgia, 30322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.